The US approves Pfizer vaccine for children aged 12-15

The US Food and Drug Administration (FDA) on Monday said it expanded the emergency use authorization for the use of the BioNTech/Pfizer coronavirus vaccination to include children and adolescents aged 12 to 15.

The vaccine by German vaccine maker BioNTech and its US partner Pfizer had previously only been approved in the country for people aged 16 and older.

Some 1.5 million Covid-19 cases in individuals 11 to 17 years of age have been reported to the country’s Centers for Disease Control and Prevention (CDC) since the beginning of the pandemic.

Some 58 per cent of all adults in the country have received at least a first dose of a coronavirus vaccine while about 44 percent of over 18’s are already fully vaccinated, according CDC figures.

Among the higher-risk group of those aged 65 and older, 83 percent have had a first dose and 71 percent are fully vaccinated.



Related Articles

Back to top button